Citospin   Report issue

For profit Phase 2 Phase 3
Founded: Valladolid Spain (2003)

Organization Overview

First Clinical Trial
2011
NCT01389661
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Citospin

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Back Pain (Phase 3)

Bone Cysts (Phase 2)

Cysts (Phase 2)

Intervertebral Disc Degeneration (Phase 3)

Low Back Pain (Phase 3)

Pneumonia (Phase 2)

Spinal Diseases (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 4
  • # of Trial APIs: 4